Literature DB >> 21233973

The many faces of lupus.

H El-Gabalawy.   

Abstract

Systemic lupus erythematosus is a multisystem disorder that presents itself in several different ways. Arthritis, dermatitis, nephritis, and pleuropericarditis are the most common features initially. Various hematologic and neuropsychiatric manifestations are also seen during the course of the disease. Anti-nuclear antibodies are the hallmark of lupus but are nonspecific and detectable in many other disorders. Once the diagnosis is established, the severity of the disease needs to be determined, in particular the extent of major organ involvement. The level of disease activity should be repeatedly estimated using clinical and laboratory parameters. Therapeutic decisions are based on disease severity and activity. Aggressive suppression of major organ inflammation and reduction of long-term toxicity are the main goals of therapy.

Entities:  

Year:  1990        PMID: 21233973      PMCID: PMC2280467     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

1.  Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.

Authors:  D D Gladman; M B Urowitz; E C Keystone
Journal:  Am J Med       Date:  1979-02       Impact factor: 4.965

2.  Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis.

Authors:  T Inoue; T Takeda; S Koda; N Negoro; M Okamura; K Amatsu; M Kohno; T Horiguchi; Y Kanayama
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

3.  The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist.

Authors:  W C Shiel; M Jason
Journal:  J Rheumatol       Date:  1989-06       Impact factor: 4.666

Review 4.  Connective tissue disease in the elderly.

Authors:  M B Stevens
Journal:  Clin Rheum Dis       Date:  1986-04

5.  ANA-negative systemic lupus erythematosus.

Authors:  W J Fessel
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

6.  Late mortality in SLE--"the price we pay for control".

Authors:  M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1980 May-Jun       Impact factor: 4.666

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Systemic lupus erythematosus and pregnancy.

Authors:  E C Tozman; M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1980 Sep-Oct       Impact factor: 4.666

9.  High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus.

Authors:  R P Kimberly; M D Lockshin; R L Sherman; J S McDougal; R D Inman; C L Christian
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

Review 10.  Antiphospholipid antibody syndromes.

Authors:  A L Parke
Journal:  Rheum Dis Clin North Am       Date:  1989-05       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.